Human Anti–Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease: The CLASSIC-I Trial
Gastroenterology - United Kingdom
doi 10.1053/j.gastro.2005.11.030
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2006
Authors
Publisher
Elsevier BV